Vanberra Signal

Fibronostics

Curated by Signal

Non-invasive algorithm-based diagnostics

Overview

Non-invasive algorithm-based diagnostics. The company uses machine learning to target specific physiological and pathological processes, in order to assess subclinical biomarker profiles in plasma for diagnosis and prognosis of disease pathologies. Applications under investigation include cardiometabolic diseases, idiopathic pulmonary fibrosis, and chronic renal diseases.

Key facts

Founded
2015

Business model

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Developer of computational tools and algorithms for omics data analysis

    Life Sciences TechnologyWashington, United States
  • Provider of a robotic exoskeleton for medical disabilities

    Life Sciences TechnologyAsheville, United States
  • Developer of home blood glucose monitor

    Life Sciences TechnologyFort Lauderdale, United States

About Fibronostics

What does Fibronostics do?

Non-invasive algorithm-based diagnostics.

Where is Fibronostics headquartered?

Fibronostics is headquartered in Orlando, United States.

When was Fibronostics founded?

Fibronostics was founded in 2015.

Which sector is Fibronostics in?

Fibronostics operates in Life Sciences Technology.

Who are Fibronostics's competitors?

Companies similar to Fibronostics include OmicsCraft, Next Level Rehab, and Home Diagnostics.